BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29731621)

  • 1. Physical inactivity is associated with decreased growth differentiation factor 11 in chronic obstructive pulmonary disease.
    Tanaka R; Sugiura H; Yamada M; Ichikawa T; Koarai A; Fujino N; Yanagisawa S; Onodera K; Numakura T; Sato K; Kyogoku Y; Sano H; Yamanaka S; Okazaki T; Tamada T; Miura M; Takahashi T; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1333-1342. PubMed ID: 29731621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Relationship Between Growth Differentiation Factor 11 and Physical Activity in Chronic Obstructive Pulmonary Disease.
    Tanaka R; Koarai A; Yamada M; Fujino N; Ichikawa T; Numakura T; Onodera K; Kyogoku Y; Tamada T; Miura M; Minakata Y; Ichinose M; Sugiura H
    Int J Chron Obstruct Pulmon Dis; 2021; 16():999-1006. PubMed ID: 33883893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults.
    Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary disease.
    Onodera K; Sugiura H; Yamada M; Koarai A; Fujino N; Yanagisawa S; Tanaka R; Numakura T; Togo S; Sato K; Kyogoku Y; Hashimoto Y; Okazaki T; Tamada T; Kobayashi S; Yanai M; Miura M; Hoshikawa Y; Okada Y; Suzuki S; Ichinose M
    Thorax; 2017 Oct; 72(10):893-904. PubMed ID: 28455454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.
    Fife E; Kostka J; Kroc Ł; Guligowska A; Pigłowska M; Sołtysik B; Kaufman-Szymczyk A; Fabianowska-Majewska K; Kostka T
    BMC Geriatr; 2018 Aug; 18(1):200. PubMed ID: 30165829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of growth differentiation factor 11 promoted the progression of chronic obstructive pulmonary disease by activating the AKT signaling pathway.
    Tang F; Ling C; Liu J
    Biomed Pharmacother; 2018 Jul; 103():691-698. PubMed ID: 29680737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients.
    do Nascimento ES; Sampaio LM; Peixoto-Souza FS; Dias FD; Gomes EL; Greiffo FR; Ligeiro de Oliveira AP; Stirbulov R; Vieira RP; Costa D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():645-53. PubMed ID: 25848241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.
    Ferrari R; Caram LM; Faganello MM; Sanchez FF; Tanni SE; Godoy I
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1553-8. PubMed ID: 26345641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gait characteristics and their associations with clinical outcomes in patients with chronic obstructive pulmonary disease.
    Iwakura M; Okura K; Shibata K; Kawagoshi A; Sugawara K; Takahashi H; Shioya T; Wakasa M
    Gait Posture; 2019 Oct; 74():60-65. PubMed ID: 31470225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is iron deficiency modulating physical activity in COPD?
    Martín-Ontiyuelo C; Rodó-Pin A; Sancho-Muñoz A; Martinez-Llorens JM; Admetlló M; Molina L; Gea J; Barreiro E; Chiaradía DAR
    Int J Chron Obstruct Pulmon Dis; 2019; 14():211-214. PubMed ID: 30666101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle.
    Sinha M; Jang YC; Oh J; Khong D; Wu EY; Manohar R; Miller C; Regalado SG; Loffredo FS; Pancoast JR; Hirshman MF; Lebowitz J; Shadrach JL; Cerletti M; Kim MJ; Serwold T; Goodyear LJ; Rosner B; Lee RT; Wagers AJ
    Science; 2014 May; 344(6184):649-52. PubMed ID: 24797481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia correlates with systemic inflammation in COPD.
    Byun MK; Cho EN; Chang J; Ahn CM; Kim HJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():669-675. PubMed ID: 28255238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?
    Pleguezuelos E; Esquinas C; Moreno E; Guirao L; Ortiz J; Garcia-Alsina J; Merí A; Miravitlles M
    Lung; 2016 Apr; 194(2):249-57. PubMed ID: 26743191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum growth differentiation factor 11 is closely related to metabolic syndrome in a Chinese cohort.
    Xu B; Huang Y; Zhang R; Tang M; He Z; Jin L; Zong Y; Hu C; Jia W
    J Diabetes Investig; 2021 Feb; 12(2):234-243. PubMed ID: 32592621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease.
    Ju C; Chen R
    PLoS One; 2014; 9(2):e84167. PubMed ID: 24558357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Phenotypes in People with COPD: Influence of Physical Activity, Sedentary Behaviour, Body Composition and Skeletal Muscle Strength.
    Xavier RF; Pereira ACAC; Lopes AC; Cavalheri V; Pinto RMC; Cukier A; Ramos EMC; Carvalho CRF
    Lung; 2019 Feb; 197(1):37-45. PubMed ID: 30430249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum GDF11 concentration is associated with a high prevalence of osteoporosis in elderly native Chinese women.
    Jin M; Song S; Guo L; Jiang T; Lin ZY
    Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1145-1147. PubMed ID: 27557752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease.
    Romme EA; Rutten EP; Smeenk FW; Spruit MA; Menheere PP; Wouters EF
    Ann Med; 2013 Feb; 45(1):91-6. PubMed ID: 22462562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
    Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.